Biotechnology & Health

Health Issues Alliance for a Stronger FDA Biodefense Biosimilars Clinical Trials Cloning Drug Importation Medicare PDUFA Plant-Made Pharmaceuticals Regulatory Stem Cell Research Universal Access to Health Care

Biotechnology combines biology and technology to heal, fuel, and feed the world. Watch BIO’s new video on YouTube (30 seconds) Visit BIO’s YouTube channel

When people are asked what they think of when they hear the word biotechnology, they respond with phrases like "biomedical research," "breakthrough medicines," "cures" and "hope for the future." Health care is, after all, the number one market for biotechnology.

A majority of BIO members are engaged in biomedical research, and to date such companies have brought 254 new medicines to market. In 2005 alone, the FDA approved 39 new biotech products and indications

BIO and its members seek to develop and bring these products to patients in a way that is expeditious, maximizes patient access and encourages continued innovation. Those goals sound simple, but achieving them requires a complex, delicately balanced legal and regulatory environment at every level - state, national and international. BIO is the leading industry voice at all those levels.

BIO: The Complete Connection
Learn more about the Biotechnology Industry Organization (BIO)
Read the Health Brochure (605 KB PDF)
Read the Complete Connection Brochure (862 KB PDF)

BIO President and CEO Jim Greenwood joined former HHS Secretary Tommy Thompson and former FDA Deputy Commissioner Scott Gottlieb to discuss biosimilars and the importance of preserving innovation as the nation moves to reform our health care system
Watch the interview